NCT05966623 (Impact of VRI) is a NA clinical trial of Video Remote Interpretation in Deafness, sponsored by University of Geneva, Switzerland.

Who is sponsoring NCT05966623?

NCT05966623 is sponsored by University of Geneva, Switzerland.

What drugs are being tested in NCT05966623?

Interventions in NCT05966623: Video Remote Interpretation.

Is NCT05966623 still recruiting?

NCT05966623 is currently status unknown. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT05966623: Impact of VRI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Impact of Vidéo Remote Sign Language Interpreting in Healthcare

Status unknown NA Last updated 29 November 2023

What this trial tests

NA trial testing Video Remote Interpretation in Deafness in 183 participants. Status unknown.

Timeline

24 August 2023

Primary endpoint
14 July 2024

14 July 2024

Quick facts

Lead sponsor	University of Geneva, Switzerland
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	183
Start date	24 August 2023
Primary completion	14 July 2024
Estimated completion	14 July 2024
Sites	2 locations across Colombia

Drugs / interventions tested

Video Remote Interpretation

Conditions studied

Deafness — all drugs for Deafness →

Sponsor

University of Geneva, Switzerland

Who can join

18 and older, any sex, with Deafness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomise study that looks at what is the effectiveness of the VRI system in improving communication outcomes between Deaf patients and doctors versus the 'available standard of care of the usual communication tools, including informal interpretation, lip or note reading, using their mobile phones to contact a formal or informal interpreter, for Deaf patients aged 18 and older in Bogota Colombia

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Video Remote Sign Language Interpreting in Health Communication for Deaf People: Protocol for a Randomized Controlled Trial.
Rivas Velarde M, Izquierdo Martinez LC, Dalal J, Martinez-R A, et al · · 2024 · cited 4× · PMID 39622021 · DOI 10.2196/64590
Video Remote Sign Language Interpreting and Health Communication for Deaf Patients: A Randomized Clinical Trial.
Rivas Velarde M, Izquierdo Martinez LC, Dalal J, Martinez-R A, et al · · 2026 · PMID 41637069 · DOI 10.1001/jamanetworkopen.2025.57189

Verify or expand the search:

Other recruiting trials for Deafness

Currently open trials in the same condition.

NCT06088953 — EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER · NA · recruiting
NCT06960616 — Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy · NA · recruiting
NCT05943509 — Hearing Program in Primary Care · NA · active not recruiting
NCT05808543 — BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants · NA · recruiting
NCT05670496 — Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Di · recruiting

Other University of Geneva, Switzerland trials

Trials by the same sponsor.

NCT07461675 — Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resec · Phase 3 · not yet recruiting
NCT07345858 — Salivary Oxytocin as a Biomarker of Psychedelic Treatment · enrolling by invitation
NCT07072338 — Promoting Mental and Cognitive Health in Old Age Through Scalable Evidence-based Interventions · NA · not yet recruiting
NCT06191835 — Implementation of a New Model of Care for Supporting Long-term Medication Adherence (Phase A) · active not recruiting
NCT06114147 — Cardiac Flow Measurements in Pregnant Women by Non Invasive Techniques · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05966623 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Geneva, Switzerland
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05966623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing